A Brain Metastases Research Platform to Tackle the Challenge of CNS Metastases in Solid Tumours
- Status
- RECRUITING
- Phase
- NA
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
Study of Nivolumab Versus Placebo in Combination With Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy in Participants With High-risk, Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Primary Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Prophylaxis With Apixaban in Transplant Eligible Patients With Multiple Myeloma Receiving Induction Therapy With IMiDs
- Status
- TERMINATED
- Phase
- PHASE2
Study of BMS-986205 and Nivolumab in Endometrial Cancer or Endometrial Carcinosarcoma That Has Not Responded to Treatment
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Effectiveness Study of Nivolumab Compared to Placebo in Prevention of Recurrent Melanoma After Complete Resection of Stage IIB/C Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
STR + Anti PD-1 Therapy in Patients with Locally Advanced Unresectable Pancreatic Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Combination of Nivolumab Plus Relatlimab in Patients With Advanced or Metastatic Soft-tissue Sarcoma: a Proof-of-concept Randomized Phase II Study
- Status
- COMPLETED
- Phase
- PHASE2
SBRT With Combination Ipilimumab/Nivolumab for Metastatic Kidney Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Dasatinib Management Among CP-CML (Chronic Phase, Chronic Myeloid Leukemia) Participants Initiating Dasatinib in a Real Life Setting
- Status
- COMPLETED
- Phase
- N/A
A Study of Combination Nivolumab and Ipilimumab Retreatment in Patients With Advanced Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
An Investigational Study to Determine the Drug Level Profile of BMS-986165 in Healthy Male Volunteers Following Transporter Inhibition.
- Status
- COMPLETED
- Phase
- PHASE1
Early Response Evaluation in NSCLC Patients Treated With Immunotherapy
- Status
- TERMINATED
- Phase
- NA
A Single and Multiple Ascending Dose Study of BMS-986318 in Healthy Participants
- Status
- WITHDRAWN
- Phase
- PHASE1
Study of Safety and Tolerability of Nivolumab Treatment Alone or in Combination With Relatlimab or Ipilimumab in Head and Neck Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Neoadjuvant Nivolumab + Palbociclib + Anastrozole in Post-Menopausal Women and Men With Primary Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Marrow Infiltrating Lymphocytes - Non-Small Cell Lung Cancer (MILs™ - NSCLC) Alone or in Combination With Nivolumab With or Without Tadalafil in Locally Advanced and Unresectable or Metastatic NSCLC
- Status
- TERMINATED
- Phase
- PHASE2
Efficacy of Re-challenge With Immune-Checkpoints Inhibitors in Advanced Non-Small-Cell Lung Cancer Patients: a Retrospective Observational Study
- Status
- COMPLETED
- Phase
- N/A
A Study to Evaluate the Safety, Tolerability, Kinetics and Repeatability of 18F-BMS-986327
- Status
- COMPLETED
- Phase
- PHASE1
Treg Modulation With CD28 and IL-6 Receptor Antagonists
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2